1-4 of 4
Marie-Cecile Legdeur
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Clofarabin Added to Standard Treatment in Adult Patients with Newly Diagnosed ALL: First Results of the Randomized Phase III HOVON-100 Study

A. W. Rijneveld, Bronno van der Holt, Okke de Weerdt, MD, Bart J. Biemond, MD PhD, Arjen van de Loosdrecht, Eefke Petersen, MD, Mar Bellido, Harry C. Schouten, MD, Walter J F M van der Velden, Dominik Selleslag, Martin R. Schipperus, Constantijn J.M. Halkes, Saskia Klein, MD, Violaine Havelange, Marinus van Marwijk Kooij, MD PhD, Marie-Cecile Legdeur, Jeannine Refos, Vincent van der Velden, PhD, Jan J Cornelissen, Crista Homburg, Valerie de Haas, MD PhD, Dries Deeren, MD, Alain Gaddiseur, Harm Sinnige, Dimitri Breems, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2606.
https://doi.org/10.1182/blood.V130.Suppl_1.2606.2606
Published: 2017
Journal Articles

Lenalidomide with or without Erythropoietin and Granulocyte-Colony Stimulating Factor Shows Efficacy in Patients with Low and Intermediate-1 Risk Myelodysplastic Syndrome with or without Del 5q, Refractory or Unlikely to Respond to Erythropoietin. Results of a HOVON89 Phase II Randomized Multicenter Study. (EudraCT 2008-002195-10)

Arjan A. van de Loosdrecht, MD PhD, Dana A Chitu, PhD, Eline MP Cremers, MD, Theresia M Westers, PhD, Canan Alhan, MD, Heleen Visser-Wisselaar, PhD, Annelies Verbrugge, Petra Muus, MD PhD, Inge de Greef, MD PhD, Pierre W Wijermans, MD, Joop H. Jansen, PhD, Saskia K. Klein, MD PhD, Edo Vellenga, MD PhD, Marie-Cecile Legdeur, MD PhD, Wendy Deenik, MD PhD, Mojca jongen-Lavrencic, MD PhD, Rien van Marwijk-Kooy, Bea Tanis, MD PhD, Jurgen Wegman, Tanja van Maanen, Gert Ossenkoppele, MD PhD
Journal: Blood
Blood (2016) 128 (22): 224.
https://doi.org/10.1182/blood.V128.22.224.224
Published: 2016
Journal Articles

Erythroid Lineage Analysis By Flow Cytometry Is of Highly Additive Value for MDS Diagnosis: A Study on Behalf of the HOVON89 Study Group

Eline MP Cremers, MD, Theresia M Westers, PhD, Canan Alhan, MD, Claudia Cali, Heleen A Visser-Wisselaar, PhD, Dana A Chitu, PhD, Marian JPL Stevens-Kroef, PhD, Pedro Silva Coelho, MD, Edo Vellenga, MDPhD, Saskia K. Klein, MDPhD, Pierre W. Wijermans, MDPhD, Georgine E De Greef, Marie-Cecile Legdeur, MD PhD, Petra Muus, MD PhD, Gert J Ossenkoppele, MD PhD, Joop H Jansen, PhD, Arjan A Van de Loosdrecht, MD PhD
Journal: Blood
Blood (2014) 124 (21): 4667.
https://doi.org/10.1182/blood.V124.21.4667.4667
Published: 2014
Journal Articles

Favorable effect of priming with granulocyte colony-stimulating factor in remission induction of acute myeloid leukemia restricted to dose escalation of cytarabine

Clinical Trials & Observations
Thomas Pabst, Edo Vellenga, Wim van Putten, Harry C. Schouten, Carlos Graux, Marie-Christiane Vekemans, Bart Biemond, Peter Sonneveld, Jakob Passweg, Leo Verdonck, Marie-Cecile Legdeur, Matthias Theobald, Emanuel Jacky, Mario Bargetzi, Johan Maertens, Gert Jan Ossenkoppele, Bob Löwenberg
Journal: Blood
Blood (2012) 119 (23): 5367–5373.
https://doi.org/10.1182/blood-2011-11-389841
Published: 2012
Includes: Supplemental data